发明名称 Osteoclast Inhibitors for Knee Conditions
摘要 Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
申请公布号 US2016113950(A1) 申请公布日期 2016.04.28
申请号 US201514967234 申请日期 2015.12.11
申请人 ANTECIP BIOVENTURES II LLC 发明人 Tabuteau Herriot;Jones Graeme
分类号 A61K31/675;A61K31/663 主分类号 A61K31/675
代理机构 代理人
主权项 1. A method of treating knee pain comprising: a. selecting a patient having knee pain, and: i. OARSI Grade 0 or Kellgren and Lawrence Grade 0 or Grade 1 of joint space narrowing, orii. pain intensity of 5 or greater measured using the 0-10 NRS or 5 cm or greater using the 10 cm VAS; and b. administering an inhibitor of osteoclast activity to the patient wherein the inhibitor of osteoclast activity is ibandronic acid or risedronic acid.
地址 New York NY US